↓ Skip to main content

Convulsive syncope related to a small dose of quetiapine in an adolescent with bipolar disorder

Overview of attention for article published in Neuropsychiatric Disease and Treatment, July 2017
Altmetric Badge

Mentioned by

twitter
1 tweeter
facebook
1 Facebook page

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Convulsive syncope related to a small dose of quetiapine in an adolescent with bipolar disorder
Published in
Neuropsychiatric Disease and Treatment, July 2017
DOI 10.2147/ndt.s137923
Pubmed ID
Authors

Jianbo Lai, Qiaoqiao Lu, Tingting Huang, Shaohua Hu, Yi Xu

Abstract

Quetiapine, an atypical antipsychotic, has been extensively used in patients with bipolar disorder. Overdose of quetiapine can result in severe complications, such as coma, seizure, respiratory depression, arrhythmia, and even death. However, the paucity of toxicological evaluation in adolescence causes more potential risks in this population. Herein, we present a case of hypotension and convulsive syncope after exposure to a small dose of quetiapine in a 16-year-old who was diagnosed with bipolar disorder. After cessation of quetiapine, no additional convulsive movements were reported. This case indicates that even in young patients without predisposing factors, close monitoring of adverse effects should be warranted for safety concerns, especially at the initiation of quetiapine treatment.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Other 1 17%
Student > Master 1 17%
Student > Ph. D. Student 1 17%
Student > Doctoral Student 1 17%
Librarian 1 17%
Other 1 17%
Readers by discipline Count As %
Medicine and Dentistry 2 33%
Nursing and Health Professions 1 17%
Unspecified 1 17%
Social Sciences 1 17%
Pharmacology, Toxicology and Pharmaceutical Science 1 17%
Other 0 0%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 July 2017.
All research outputs
#10,016,527
of 12,517,383 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,644
of 2,120 outputs
Outputs of similar age
#192,764
of 262,740 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#74
of 94 outputs
Altmetric has tracked 12,517,383 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,120 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one is in the 8th percentile – i.e., 8% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 262,740 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 94 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.